IQnovate signs first deal since NSX listing
15 March, 2012 by Dylan Bushell-EmblingContract medical company IQnovate (NSX:IQN) has signed a preliminary agreement to provide commercialisation services for JH Biotech Australasia.
Phosphagenics signs skincare deal in Korea
15 March, 2012 by Dylan Bushell-EmblingDrug delivery company Phosphagenics (ASX:POH) has secured an agreement to supply its BioElixia skincare products to a Korean distributor.
BioPro survey to see what’s hot in professional development
15 March, 2012 by AusBiotechAusBiotech’s biotechnology-specific professional development program is running an express survey to see if it is meeting your professional development needs.
Celxel implants CardioCel in valve reconstructs
13 March, 2012 by Dylan Bushell-EmblingAllied Healthcare's (ASX:AHZ) tissue engineering division has implanted its CardioCel patch in heart valve reconstructions, during a phase I animal trial.
Anteo licenses Mix&Go to eBiosciences
13 March, 2012 by Dylan Bushell-EmblingAnteo Diagnostics (ASX:ADO) has signed a potentially lucrative licensing deal for its Mix&Go molecular glue with US-based eBiosciences.
AusBiotech delegation of CEOs to Parliament House
13 March, 2012 by AusBiotechAusBiotech’s CEO, a number of its directors and 20 of its member CEOs and executives will tomorrow be hosted at Parliament House for this year’s CEO Forum addressing issues in innovation policy and programs.
Salt tolerant wheat could boost yields by 25%
12 March, 2012 by Tim DeanA new variety of salt tolerance durum wheat produced by Australian researchers could significant boost yields here and overseas and help farmers respond to climate change.
TGA quarantines contaminated human albumin from CSL
09 March, 2012 by Tim DeanHuman albumin manufactured by CSL has been quarantined by the Therapeutic Goods Administration due to fears it may be contaminated with ethylene glycol.
Osprey Medical to raise $20m in IPO
08 March, 2012 by Dylan Bushell-EmblingOsprey Medical, a US-headquartered medical device company developing products based on Australian research, plans to list on the ASX via a $20m IPO.
Latest AusBiotech journal features special medtech edition
08 March, 2012 by AusBiotechAusBiotech is pleased to announce that the first edition for 2012 (March issue) of AusBiotech’s journal, Australasian Biotechnology, is now published, featuring a special medical technology edition.
Minomic gets $5m investment funding
08 March, 2012 by Dylan Bushell-EmblingThe Carnegie Innovation Fund has committed to invest up to $5 million in NSW-based prostate cancer diagnostic company Minomic International.
Bionomics gains after All Ordinaries rebalance
08 March, 2012 by Dylan Bushell-EmblingBionomics (ASX:BNO) shares grew 12.4% in two days after Standard & Poor's added the company to the S&P All Ordinaries index during its latest rebalance.
Last chance to catch this year’s BD Forum… in Queensland
06 March, 2012 by AusBiotechAusBiotech has announced the final chance for biotech business development professionals to attend the annual dedicated Business Development Forum and Workshop (BD Forum) in Queensland.
Phosphagenics signs deal in Japan
05 March, 2012 by Dylan Bushell-EmblingJapan's Nippon Zoki Pharmaceutical has agreed to assess Phosphagenics' (ASX:POH) TPM/diclofenac pain patch for its suitability in the Japan and US markets.
ACPFG, DuPont expand agbiotech research deal
02 March, 2012 by Dylan Bushell-EmblingDuPont subsidiary Pioneer Hi-Breed and agricultural research body ACPFG have expanded a longstanding agreement to collaborate on agricultural biotechnology R&D.
